Dr Diana Clayton
MD, PhD, FRCP
GMC number: 6058325
Practicing since: 1992
Endocrinology and Diabetes Mellitus, General (internal) Medicine
- Appointments by arrangement
Or call us on
Dr Clayton Qualified from Vilnius University in 1992 and completed postgraduate training in General Medicine and Endocrinology at University Hospital, Vilnius, Lithuania in 1998 and obtained a PhD from Vilnius University with distinction in 2002. Dr Clayton moved to the UK and was appointed to Consultant Physician & Endocrinologist in 2004 having spent 2 years in research at Keele University, Staffordshire. Dr Clayton was awarded FRCP London in 2010 as a result of the excellent teaching and training of junior doctors and undergraduate students.
Since moving to Plymouth in 2015, Dr Clayton was involved in developing services for diabetes (joint foot clinic) as well as general diabetes. Dr Clayton has broad experience in all aspects of endocrinology including thyroid disease, metabolic bone disease, male and female reproductive endocrinology, adrenal dysfunction, and endocrine aspects of obesity including post weight loss surgery. Dr Clayton has developed a ‘transition’ endocrine clinic with paediatricians for children progressing to adulthood.
Dr Clayton is a member of diabetes and neuroendocrine MDT’s and provides
regular advice to diabetes specialist nurses and endocrine nurses. Dr Clayton has
broad experience in acute general internal medicine from regular work on a
short stay ward and is a clinical lead involved in the ‘acute take’ at
General Internal Medicine
English, Lithuanian, Russian
Treatments and tests offered by Dr Diana Clayton at Nuffield Health
- Endocrine investigations
Locations Dr Diana Clayton works with
Raskauskiene D. Govind A. Obhrai M. Clayton R.N. Polycystic ovaries on ultrasound scan indicate decreased insulin sensitivity in sisters of PCOS women. Journal of Clinical Endocrinology and Metabolism. 2005; 2063-2067
Raskauskiene D., Clayton R.N. Obesity and PCOS. In Obesity and Diabetes Ed Barnett A & Kumar S. Wiley & Sons, London 2009
Clayton RN, Raskauskiene D, Reulen R, Jones PW, Mortality and Morbidity in Cushing’s disease over 50 years in Stoke-on-Trent: audit and meta-analysis of literature. Journal of Clinical Endocrinology & Metabolism. 2011: 96:632-642
Palalau A, Raskauskiene D (2011) Management of primary hyperparathyroidism. Poster; British Endocrine Societies Annual Meeting, Birmingham, Apr. 2011.
Clayton RN, Raskauskiene D, Reulen R, Jones PW, Mortality and Morbidity in Cushing’s disease over 50 years in Stoke-on-Trent: audit and meta-analysis of literature. Journal of Clinical Endocrinology and Metabolism. 2011: 96:632-642.
A.Khan A, Puttanna A, Raskauskiene D. Amiodarone-induced thyrotoxicosis: type 1 or type 2? BMJ Case Rep. 2014 Oct 27; 2014.
Pappachan JM, Raskauskiene D, Sriraman R, Edavalath M, Hanna
FW. Diagnosis and management of pheochromocytoma: a practical guide to
clinicians. Curr Hypertens Rep. 2014 Jul;16 (7):442
- Fellow of Royal College of Physicians London
- British Endocrine Society
- British Thyroid Association
Other posts held
- Consultant Physician Endocrinologist & Diabetologist Derriford Hospital
Insurers Dr Diana Clayton works with
Dr Diana Clayton works with the following private medical insurance providers:
- Aviva Health
- AXA PPP Healthcare
- AXA PPP International
- Healix Healthcare
- Vitality Health (Pru Health)
Dr Diana Clayton does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.
Dr Diana Clayton does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.
Dr Diana Clayton does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.